ArticleInternational journal of general medicine2026
Comparison of Postoperative Visual Acuity and Visual Quality Among Vision Enhancing Bifocal Intraocular Lenses (AM4UH), Bifocal IOLs, and Monofocal IOLs.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare visual acuity and visual quality after implantation of Vision Enhancing bifocal intraocular lens (IOL), bifocal IOL or monofocal IOL in patients with age-related cataract. Methods: Retrospective study. Group A was implanted with Vision Enhancing bifocal (bifocal combined extended depth of focus (EDOF)) IOL (Eyebright Medical Technology (Beijing) Co. Ltd. China: AM4UH, 21 eyes), group B was implanted with bifocal IOL (Johnson & Johnson, USA: ZMB00, 21 eyes), and group C was implanted with monofocal IOL (Eyebright Medical Technology (Beijing) Co. Ltd. China: A1UL22, 21 eyes). At 3 months postoperatively, uncorrected distance visual acuity (UDVA) was compared among 3 groups, while uncorrected near visual acuity (UNVA) and uncorrected intermediate visual acuity (UIVA), defocus curves, and visual quality questionnaire results were compared between Group A and B. Results: There was no statistically significant difference in UDVA among three groups postoperatively (P > 0.05); in terms of UIVA and UNVA, group A was better than group B (P < 0.05); the defocus curves showed that group A was close to bimodal but tended to be flat, while group B was bimodal; groups A and B became spectacle-independent postoperatively, and 40% of patients in group B reported the halo phenomenon, especially when driving at night. Conclusion: Vision Enhancing bifocal IOL (AM4UH) exhibited a better UIVA and UNVA, indicating a continuous visual range. And patients implanted with AM4UH achieved postoperative spectacle independence, with less visual disturbance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.